Peter Atadja

Peter Atadja

Chief Tech/Sci/R&D Officer at CommBio Therapeutics Co., Ltd.

64 year
Health Technology
Consumer Services

Profile

Peter Atadja is currently the Chief Scientific Officer at CommBio Therapeutics Co., Ltd.
He previously worked at Novartis Pharmaceuticals Corp.
as the Executive Director & Head-Drug Discovery from 1997 to 2021.
Additionally, he served as an Independent Director at Traws Pharma, Inc. from 2022 to 2024.
Dr. Atadja also held the position of Chief Scientific Officer at K36 Therapeutics, Inc. in the past.
He holds a doctorate degree from the University of Calgary, a graduate degree from The Hebrew University of Jerusalem, and an undergraduate degree from Kwame Nkrumah University of Science & Technology.

Peter Atadja active positions

CompaniesPositionStart
CommBio Therapeutics Co., Ltd. Chief Tech/Sci/R&D Officer -
All active positions of Peter Atadja

Former positions of Peter Atadja

CompaniesPositionEnd
TRAWS PHARMA, INC. Director/Board Member 2024-03-31
Director/Board Member 2020-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Peter Atadja's experience

Training of Peter Atadja

University of Calgary Doctorate Degree
The Hebrew University of Jerusalem Graduate Degree
Kwame Nkrumah University of Science & Technology Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Atadja's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
TRAWS PHARMA, INC.

Health Technology

Private companies3

Health Technology

CommBio Therapeutics Co., Ltd.

Health Technology

See company connections